Equifax Surges 18% Into Earnings as Analyst Targets Lag the Rally

Equifax reports its Q3 results this morning, arriving at the print having rallied 18.4% over the past week to $176.54, a move that has outpaced every major peer and put the stock ahead of where most analysts thought it would be.

The rally itself is the sharpest tension in the setup. Closest peer TransUnion gained 10.7% over the same period. Gartner added 9.7%. Verisk rose 6.6%. Equifax ran roughly double the peer group median. That gap makes the current price awkward against the analyst consensus: the mean target of $194.30 now implies only about 10% further upside from $176.54, a far narrower cushion than the 22% implied by prior-week closes. The stock has effectively run through a portion of the return the Street modelled months before the quarter was reported.

The analyst community had been moving in one direction for weeks, and that direction was lower. Morgan Stanley cut its target to $205 from $225, maintaining Overweight. RBC trimmed to $177 from $194, also keeping its positive rating. Oppenheimer went further and downgraded to Perform from Outperform, the only outright rating cut in the cluster. Mizuho lowered its target to $185 from $210 this past Sunday, the day before the original October 20 earnings date. The pattern across all of these was consistent: firms kept constructive ratings but pulled in their numbers, citing mortgage origination pressure and the pace of recovery in Equifax's USIS segment. At $176.54, the RBC target of $177 is effectively at the current price. The Street's caution has not gone away; the stock has simply closed the gap.

Options positioning has also shifted since the prior articles on this company. The put/call ratio has eased to 1.58, still above the 52-week low of 0.50 but now 1.6 standard deviations below the 20-day average of 1.94. For much of October, the PCR ran above 2.0, a level associated with heavy put demand. The drop toward calls in recent sessions aligns with the price action: investors who held downside protection through the quarter have been unwinding it as the stock moved higher. Short interest, meanwhile, remains at the lower end of its recent range at 4.3% of the float, down nearly 30% from a month ago. Borrow costs are negligible at 0.48% and availability is exceptionally loose, so there is no squeeze dynamic in the lending market to explain the move.

The Q3 print will test whether the revenue trajectory in USIS and workforce solutions can justify a stock trading back near the price points that prompted analyst target cuts just two weeks ago.